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Abstract
 The report of World Health Organization (WHO) shows that India tops the world with the largest
number of diabetic subjects. This increase is attributed to the rapid epidemiological transition accompanied
by urbanization, which is occurring in India. There is very little data regarding the influence of affluence
on the prevalence of diabetes and its complications particularly retinopathy in the Indian population.
Furthermore, there are very few studies comparing the urban / rural prevalence of diabetes and its
complications. The Chennai Urban Rural Epidemiology Study  (CURES) is designed to answer the
above questions. CURES is initially planned as a cross-sectional study to evolve later into a longitudinal
study. Subjects for the urban component of the CURES have been recruited from within the corporation
limits of Chennai City. Chennai (formerly Madras), the largest city in Southern India and the fourth
largest in India has been divided into 10 zones and 155 wards.  46 wards were selected by a systematic
random sampling method to represent the whole of Chennai. Twenty thousand and one individuals
were recruited for the study, this number being derived based on a sample size calculation.
The study has three phases. Phase one is a door to door survey which includes a questionnaire,
anthropometric, fasting capillary blood glucose and blood pressure measurements. Phase two focussed
on the prevalence of diabetic complications particularly retinopathy using standardized techniques like
retinal photography etc. Diabetic subjects identified in phase one and age and sex matched non-diabetic
subjects will participate in these studies.  Phase three will include more detailed studies like clinical,
biochemical and vascular studies on a sub-sample of the study subjects selected on a stratified basis
from phase one. CURES is perhaps one of the largest systematic population based studies to be done in
India in the field of diabetes and its complications like retinopathy, nephropathy and neuropathy.
a major implication on the present and future disease patterns
in India with particular reference to non-communicable
diseases like diabetes and coronary artery disease (CAD).3,4
Both CAD and diabetes are consequences of the insulin
resistance syndrome (IRS) also known as the metabolic
syndrome. This is a cluster of metabolic abnormalities
comprising of abdominal obesity, glucose intolerance / type
2 diabetes mellitus, dyslipidemia and hypertension.5 Our earlier
population based study the Chennai Urban Population Study
(CUPS) showed intra-urban difference in the prevalence of
various components of the IRS.6 This study also reported on
the prevalence of hypertension, dyslipidemia, CAD, peripheral
vascular disease (PVD) and diabetic retinopathy.6-8 However,
the limitation of the CUPS was that it was conducted in a
selected population in Chennai representing the middle and
low-income group. This restricts extrapolating the obtained
results to whole of population of Chennai. Moreover the
study numbers being small (n=1262), CUPS was underpowered
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INTRODUCTION
Epidemiology is defined as “the study of the distributionand determinants of health related status or events in
specified populations”.1 Epidemiological studies highlight the
health issues currently affecting the nation and also help us
to delineate the risk factors associated with the disease.
Furthermore these studies also guide us to estimate the
disease burden of the future, which is essential to plan
preventive health strategies.
Currently, India is passing through an epidemiological
transition due to rapid urbanization coupled with economic
growth.2 The changing pattern in the economy is obvious
from the current urbanization rate which stands at 35%
compared to 15% in the 1950’s. This rapid transition will have
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to answer several questions particularly regarding prevalence
of complications of diabetes like retinopathy, neuropathy and
nephropathy as there were only a total of 152 diabetic subjects
in CUPS.  Finally there was no rural component.
Furthermore, there is paucity of data  on the prevalence of
diabetic retinopathy in native Indians. The available studies
indicate the prevalence to be much lower than that compared
to Europeans.9 The reason for this decreased prevalence of
diabetic retinopathy in contrast to the increased diabetes
prevalence in Indians is not very clear.
This forms the background for undertaking a study called
the “Chennai Urban Rural Epidemiology Study” (CURES),
which is planned to be a large cross-sectional study, of
representative samples of the whole of Chennai (representing
the urban component) and villages around Chennai
(representing the rural component).
The CURES study commenced in August 2001 with the
objective of comparing the prevalence of the various
components of IRS in an urban and rural South Indian
population and also to assess the prevalence of diabetes-
associated complications, particularly retinopathy and
disorders like glaucoma and cataract in Type 2 diabetic
subjects. This paper will discuss the study design and
methodologies adopted for CURES in the urban component
of the study.
Study design
CURES is planned as a cross-sectional field survey, which
measures the prevalence of disease. This design has been
adopted by several countries on representative samples of
their populations focusing on personal and demographic
characteristics, illnesses and health related habits.  According
to the World Health Organization (WHO), in epidemiological
research, cross-sectional field survey is the first step to obtain
accurate baseline values to later plan a prospective follow up
study.
Sample size calculation
Earlier published studies on selected populations in India
have suggested that the prevalence of known diabetes in
urban areas is around 5.0%.6,10 If we are to assess the risk
factors of diabetic retinopathy, we require a minimum of 200
subjects affected by retinopathy. Based on the prevalence
rate for diabetic retinopathy obtained in CUPS in known
diabetes (21.4%),8 we require 1000 diabetic subjects in order
to have 200 subjects affected by diabetic retinopathy. To
obtain 1000 adult (≥ 20 years) diabetic individuals, a sample
size range between 16,000 to 24,000 was calculated assessing
99% confidence intervals and 0.5% error. The upper limit of
24,000 was taken as our target. However, considering a drop
out rate of 10% among the diabetic subjects, we decided to
recruit 26,000 individuals for the study.
Sampling design
Chennai (formerly Madras), the largest city in Southern
India and the fourth largest in India is located on the
Coromandel coast of the bay of Bengal and has a population
of 4.216 million.11 The whole of Chennai has been divided
into 10 zones and 155 wards by the Chennai Corporation.
The sampling for CURES was based on the model of
systematic random sampling, wherein, of the 155 wards, 46
wards were selected to represent all the 10 zones. The total
sample size of 26,000 individuals was selected from these 46
wards. The sample distribution in each ward within these
zones is based on the proportion of their population in that
particular zone. The wards selected for the study are shown
in Fig. 1. Further, within each ward, every third lane or road,
following the right hand rule was surveyed. Such a sampling
approach was chosen as it enabled the arrival of an equitable
distribution of the entire Chennai population while ensuring
that the sampling error is kept to a minimum. Another
advantage is the simplicity of the administrative procedures
involved. All men and women ≥ 20 years of age were
considered eligible for the study.
PHASES OF THE STUDY:
CURES  was conducted in three phases (Fig. 2):
Phase one was the main survey conducted in the field,
which involved a door-to-door survey in the selected wards.
Fig. 1 : Corporation of Chennai city map showing CURES sampling
frame
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Phase two a detailed study of the vascular complications,
particularly retinal photography and detailed examination of
the eye in all diabetic subjects identified in Phase 1 with age
and sex matched non-diabetic subjects as controls.
Phase three  aimed at studying the normal distribution of
various measures inclusive of biochemical parameters,
obesity and anthropometric indices, atherosclerotic markers
like carotid intimal medial thickness and detailed eye
examination to assess eye disorders in a sub-sample of the
total population recruited for CURES.
PHASE I OF THE STUDY
The first phase of the study was done with the help of an
external agency. This phase included training of survey team,
conducting a pilot study, obtaining the consent of the study
individuals and finally conducting of survey itself (Fig. 3).
a. Intensive training programme:
Training was provided on a one to one basis  to all the  50
-team members and lasted for 5 weeks consisting of training
sessions of  2-3 hours per day on all  working days of the
week.  The training programme was conducted by the
epidemiology team of the Madras Diabetes Research
Foundation before the survey commenced. The aim was to
ensure that each member of the team was well trained in
various procedures which included filling out the
questionnaire which has been validated and various
anthropometric, fasting blood glucose and blood pressure
measurements. Anthropometric measurements included
height, weight, waist, hip and mid-arm circumference
measurements. The trainees were educated to use the
electronic  machine to measure blood pressure and the
glucometer for estimating fasting capillary blood glucose.
The main objective of this training was to avoid biases or
errors in any of the procedures employed.
Each trainee was evaluated individually. SS and DM took
turns and cross-verified and validated the interview and
measurements done by the trainees. The trainees were
considered fit to conduct the study only if they achieved
minimum error rates for all the measurements.
b. Quality controls:
The machines used for the study namely the electronic BP
apparatus and glucometers were validated. The glucometer
was calibrated every day with a calibrator provided along
with the machine. Reproducibility for the glucometer was
assessed by measuring blood glucose for the same patient
six times as well as by evaluating the machines against each
other. The machines were used for the study only if the
coefficient of variation were <5%. Similar procedure was
followed for the blood pressure machines.
Selected questions from the questionnaire were used for
validation purposes. These included questions related to
knowledge on diabetes, medical history and family history of
diabetes. The questionnaire was retested on 50 subjects after
5 weeks and correlation analysis revealed good
reproducibility. Monitoring the persons conducting the
survey was done randomly rechecking the data and values,
with particular reference to blood pressure and fasting blood
sugar estimations.
c. Pilot study:
Initially, a pilot study was conducted among a sub-
population of 100 subjects to overcome the practical
difficulties of performing the study. The study was conducted
as a four-step procedure. The first step was selection of the
participants. Next the informed consent was obtained after
which an interview was conducted and finally fasting capillary
Fig. 2 : Phases of CURES
Footnote: Only the basic study design is depicted here. There are
many other additional sub-studies from CURES for which the
methodology may vary.
Fig. 3 : Phase 1 of CURES
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blood glucose and blood pressure was measured. Five teams
with four members each conducted the pilot study. The teams
visited selected households one day in advance to request
eligible individuals to observe a minimum of 8 hours fast
prior to  estimation of  the fasting capillary blood glucose
levels the next morning. The pilot study revealed that it took
45 minutes to collect all the information, which included the
interview (25 minutes), anthropometric measurements (5
minutes) and measuring fasting capillary blood glucose levels
and blood pressure (15 minutes). The pilot study concluded
that there was no questionnaire fatigue and a good response
rate provided the confidence to proceed with the study.
d. Obtaining consent and ethical committee approval:
 Ethical committee approval was obtained prior to the start
of the study and an informed consent was obtained from all
the study subjects. Each step in the study was verbally
explained to the participant and adequate opportunities were
given for discussion of questions with the interviewer. A
written description of the study was shown to the participant
for obtaining his/ her consent. The consent form was
translated into the regional language (Tamil) for the
convenience of individuals who did not know English. It was
also back translated to check the accuracy of the translation.
The consent form was explained to each participant and
consent was obtained only after the interviewer was sure
that the participant understood and accepted the contents.
e. Method of the Survey:
The main study was conducted using the four step
procedure as adopted in the pilot study.
Questionnaire: The questionnaire which was administered
to the study subjects included details regarding demographic
and socioeconomic characteristics like participant’s self-
reported age, sex, educational status, family and individual
income, type of house, etc. Behavioural aspects included
self-reported current and past smoking and alcohol use. Health
awareness included knowledge regarding prevalence, risk
factors and prevention of diabetes. Health conditions were
documented based on self-reported history of diabetes,
hypertension and cardiovascular disease (chest pain, heart
attack and stroke). Family history for all of the above
conditions was also collected. Health economics data included
the amount spent on health and details of hospitalization for
the past five years. Details pertaining to psychosocial aspects
like depression, stress and hopelessness were obtained using
standard instruments. Physical activity was assessed by
using a standard scale, which was validated earlier in a South
Indian population.12
Anthropometric measurements
Height was measured with a tape to the nearest cm. Subjects
were requested to stand upright without shoes with their
back against the wall, heels together and eyes directed
forward.
Weight was measured with traditional spring balance that
was kept on a firm horizontal surface. The scale was checked
every day and calibration was done with “known” weights.
Subjects were asked to wear light clothing and weight was
recorded to the nearest 0.5 kg.
Body mass index  (BMI) was calculated using the formula:
weight (Kg)/height (m2).
Waist was measured using a non-stretchable fibre measure
tape. The participants were asked to stand erect in a relaxed
position with both feet together, one layer of clothing was
accepted. Waist girth was measured as the smallest horizontal
girth between the costal margins and the iliac crests at minimal
respiration.
Hip was taken as the greatest circumference at the level of
greater trochanters (the widest portion of the hip) on both
sides. Measurements were made to the nearest centimeter.
Waist and hip ratio (WHR) was calculated by dividing the
waist circumference (cm) by the hip circumference (cm).
Blood pressure and blood glucose measurement: Blood
pressure was recorded in the sitting position in the right arm
to the nearest 1mm Hg using the electronic OMRON machine
(Omran Corporation,Tokyo, Japan). Two readings were taken
5 minutes apart and the mean of the two was taken as the
blood pressure. Fasting capillary blood glucose was
determined using the glucometer (Lifescan Johnson &
Johnson, Milpitas, California, USA).
Definitions of variables used in Phase I of CURES:
Diabetes was diagnosed based on the past medical history,
drug treatment for diabetes, and/or using the ADA fasting
criteria.13
Current age was defined as the age at the time of
examination (2001 - 2002).
Duration of diabetes was taken as the difference between
the date the individuals were first told by a medical practitioner
that they had diabetes or the first time their fasting blood
sugar level met the ADA diabetes diagnostic criteria or when
the hyperglycaemic medications were started to the date of
the examination.
Hypertension was diagnosed based on past medical
history, drug treatment for diabetes, and/or if the subjects
had systolic blood pressure (SBP) of 140 mmHg or greater
and/or diastolic blood pressure  (DBP) of 90 mmHg.14
PHASE II OF CURES
From the Phase I of the study, all the known diabetic
subjects and age and sex matched non-diabetic subjects were
invited to the centre for detailed studies on various vascular
complications  (the Diabetes Complication Study).  In Phase
2 the study subjects were requested to undergo detailed
anthropometric measurements, complete biochemical tests
and the special tests (Fig. 4). Informed consent was once
again obtained from every participant to undergo this phase
of the study.
Anthropometric measurements
Weight, waist and hip were again measured using methods
as mentioned in Phase 1.
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Skin fold measurement
All the measurements were taken in duplicate on the right
side of the body with the subject lightly clothed.
Measurements were taken to the nearest millimeter using
Lange skinfold calipers (Cambridge Scientific Industries, Inc,
Cambridge, Maryland).  The sites of measurement were biceps,
triceps, subscapular, chest, supra-iliac, mid-axillary, abdomen,
mid-thigh and medial calf using standard techniques.15
The skin was firmly grasped by the thumb and index finger
of the left hand about 1cm or 1/2 inch proximal to the skinfold
site and was pulled away from the body.  The caliper held in
the right hand was placed perpendicular to the long axis of
the skin with the caliper’s dial facing up so that it was easily
readable.  The caliper tips were placed on the site of
measurement about 1cm or 1/2 inch distal to the fingers
holding the skin, so that pressure from the fingers did not
affect the measured value.
Triceps:  The triceps skinfold thickness was measured on
the posterior aspect of the right arm, over the triceps muscle,
midway between the lateral projection of the acromion process
of the scapula and the inferior margin of the olecranon process
of the ulna.
Biceps: The biceps skinfold is a vertical fold on the anterior
aspect of the arm, over the belly of the biceps muscle, directly
opposite to the triceps skinfold site.
Chest:   The chest or pectoral skinfold measurements were
made using a skinfold with its long axis running from the top
of the anterior axillary fold to the nipple.  The skinfold was
grasped as high as possible at the anterior axillary fold, and
the thickness of the fat fold was measured 1cm or 1/2 inch
below the fingers along the axis.
Subscapular: The subscapular thickness was measured
1cm below the inferior  angle of the scapula, which was
identified by gentle palpation of the lower end of the  scapula
with the patient standing with his arms by his side.
Midaxillary: This was measured at the level of the right
midaxillary line:  (where it is met by a horizontal line from the
xiphisternum  (at the bottom of the sternum where the xiphoid
process begins).  It was measured with the subject standing
erect and with the right arm slightly abducted and flexed
(bent posteriorly).
Suprailiac: This skinfold was measured just above the iliac
crest in the midaxillary line.
Abdomen: The study subjects were asked to stand erect
with their body weight evenly distributed on both feet. They
were then asked to breathe evenly and relax their abdominal
muscles. A horizontal fold of skin 1 cm below the umbilicus
and 3 cm laterally (to the right) was then measured.
Thigh:  This was measured as vertical skins fold in the
anterior aspect of the thigh midway between the inguinal
crease and the upper border of the patella in the midline.
Flexing the subject’s hip helped to locate the inguinal crease.
Medial calf:  The point of maximum calf circumference was
marked at the medial (inner) aspect of the calf.  A vertical skin
fold was grasped about 1 cm proximal to the marked site and
measured at that site.
Sagittal abdominal diameter: Abdominal height (sagittal
abdominal diameter), defined as the width of the abdomen at
the waist level, was measured with a sliding beam abdominal
caliper (Holtain-Kahn abdominal caliper; Holtain, Dyfed,
Wales) with the subject lying supine on the examination
table.16
Biochemical tests
Fasting and 2 hour post-load (post 75-g oral glucose load
- oral glucose tolerance test [OGTT]) plasma glucose
concentrations were done in all subjects except in known
diabetic subjects. Biochemical analysis was done on a Hitachi
- 912 Autoanalyser (Hitachi, Germany) using kits supplied by
Roche Diagnositics (Basel, Switzerland). Fasting plasma
glucose (GOD - POD method), serum cholesterol (CHOD-
PAP method), serum triglycerides (GPO-PAP method) and
HDL cholesterol (direct method) were also measured.
Glycated haemoglobin (HbA1C) was estimated by high-
pressure liquid chromatography using the Variant machine
(Bio-Rad, Hercules, Calif., USA).  Serum insulin concentration
was estimated using Dako kits (Dako, Glostrup, Denmark).
Special investigations
Doppler:
The diagnosis of peripheral vascular disease was based
on palpation of foot pulses, clinical symptoms of claudication
and measurement of an ankle-branchial index (ABI). This
included recording of pressure tracings using the KODY
Fig. 4 : Phase 2 and 3 of CURES
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Vaslab Machine (Kody Labs, Chennai, India).  Blood pressure
recordings were made of the brachial pulses in the upper
limb.  Similar recordings are made of the dorsalis pedis and
posterior tibial pulses in the lower limb by inflating the cuff
proximal to the ankle and the mean of these two readings was
taken as the ankle pressure.   An ABI index of less than 0.9
was the criteria used for the diagnosis of peripheral vascular
disease.17
Biothesiometry:
A biothesiometer (Biomedical Instrument Co., Newbury,
Ohio, USA) was used to assess vibratory perception threshold
(VPT) of the great toe in a standardized fashion. Subjects
were initially requested  to remove their shoes and socks and
lie supine on a couch for atleast 5 minutes before the
measurements were done. The foot was kept warm during the
measurement and as the room was air-conditioned, the
temperature of the room was around 25°C. The biothesiometer
tactor, which vibrates at 100 Hz with an amplitude proportional
to the square of the applied voltage was applied perpendicular
to the test site with a constant and firm pressure. Subjects
were initially familiarised with the sensation by holding the
tactor against the distal palmar surface. VPT was then
measured at the distal plantar surface of the right great toe.
The voltage was slowly increased at the rate of 1 V/s and the
VPT was defined as the moment when the subject indicated
he / she first felt the vibration. The voltage at which this
occurred was recorded. Three further cycles were performed
and the average value was taken.
Neuropathy was diagnosed using a neuropathy scoring
system (NSS), which included symptom evaluation, tendon
reflexes and sensory tests in addition to the biothesiometry
readings.
Carotid Doppler:
The intimal as well as medial thickness of the carotid
arteries were determined using a high resolution B mode
ultrasonography system (Logic 400 GE, Milwaukee, Wis.,
USA) having an electric linear transducer midfrequency of
7.5 MHz.  The images obtained were recorded and
photographed.  The scanning was done for an average of 20
min.  The intimal plus medial thickness (IMT) was measured
as the distance from the leading edge of the first echogenic
line to the second echogenic line.  The first echogenic line
represented the lumen intimal interface and the second line
was produced by the collagen - containing upper layer of the
intimal adventitia. Six well defined arterial wall segments were
measured in each (right and left) carotid system: the near wall
and far wall of the proximal 1 cm of the internal carotid artery,
the near wall and far wall of the carotid bifurcation, beginning
at the tip of the flow divider, and extending 1 cm below this
point, and the near wall and far wall of the arterial segment,
extending 1 cm below the tip of the flow divider into the
common carotid artery. The reproducibility of the IMT
measurement was examined by conducting another scanning
1 week later on 20 subjects by same sonographer. Correlation
analysis revealed a fairly good correlation between the IMT
measurements.
Electrocardiogram:
A resting 12-lead electrocardiogram (ECG) was carried out
on all subjects.  Minnesota coding was used to grade the
ECG.  ECG changes suggestive of ST-segment depression
(Minnesota codes 1-1-1 to 1-1-7) or Q-wave changes
(Minnesota codes 4-1 to 4-2) or T-wave changes (Minnesota
codes 5-1 to 5-3) were taken as evidence of coronary artery
disease.
Studies on ocular changes in diabetes
A comprehensive ocular examination was done in all study
subjects by trained optometrists and technicians.
Visual acuity was recorded by trained optometrists using
an illuminated Snellen’s chart. The presenting and best-
corrected visual acuity was documented separately for each
eye.
A complete slit lamp examination was done and the depth
of anterior chamber was assessed using Van Herrick’s
technique, Cataract if present was documented as cortical
lens changes greater than 3 and / or post-subcapsular cataract
> 2 and / or nuclear opalescence > 3 (Lens Opacity
Classification System) - [LOCS].18
The intra-ocular pressure (IOP) was measured using
Goldman applanation tonometer. The average of three
independent readings was taken as the final intra-ocular
pressure of each eye.
Gonioscopy was done using the Sussman’s hand held
four-mirror gonio lens to assess the angle structures after
instilling one drop of 4% xylocaine to each eye. The angle
grading was done in each eye from Grade 0 - 4 using Schafer’s
method for grading of the angles.
Automated full threshold visual fields were done using
the Humphrey visual field analyzer to check for any visual
field loss by using 24 - 2 SITA standard field chart with
appropriate near correction. If the visual field obtained was
unreliable or abnormal, it was repeated subsequently when
the subject was relaxed.
Corneal aesthesiometry:
The corneal thickness was measured using a Cochet
Bonnet aesthesiometer. The aesthesiometer filament was fully
extended to 60 mm. The tip of the fiber was steadily advanced
towards the cornea. When the end-plate of nylon filament
was found to be in contact with cornea a mild pressure was
exerted such that fiber had the slightest bend just visible.
The response was assessed either by subjective response of
patient or by objective blinking or withdrawal response. If
there was no response, the fiber length was shortened in
steps of 5 mm each time and procedure was repeated till a
response was elicited. At times ‘blanks’ were given to test
patients reliability and only reliable data was included.
Retinal photography:
Fundus  photography was done to evaluate changes in
the retina and the optic disc. The pupils were dilated using
one drop each of phenylepherine 10% and tropicamide 1%
into both eyes and the drops were repeated until the best
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possible mydriasis was obtained. Four field colour retinal
photography was carried out by a trained photographer with
a Zeiss FF 450 plus camera using 35 mm colour transparencies.
The four fields taken were stereoscopic pictures of the macula,
disc superior temporal, and inferior temporal quadrants. If
photography of any particular eye or any field was not
possible due to inadequate dilatation, inability to cooperate
properly or opacities of the media, then these were specified
as missing eye or fields.
Grading of retinal photographs: The photographs were
coded using an identification number and assessed in a
masked manner in order  to minimize any possible bias. The
photographs were graded against standard  photographs of
the Early Treatment Diabetic Retinopathy Study (ETDRS)
grading system for severity of retinopathy.19
Definition of retinopathy:
Levels of retinopathy based on presence and severity of
lesions.
Level 10 : No retinopathy
Level 20 : Presence of definite microaneurysms only.
Level 30 - 51 : Lesions of non-proliferative retinopathy ordered
by severity.
Level 60 - 85 :  Proliferative retinopathy also ordered by
severity
In addition to grading to severity of retinopathy presence
of clinically significant edema was also determined.19
Photographs were assessed and the study subjects were
assigned retinopathy level. The final diagnosis was
determined by the grade of the worse eye.
Optic disc evaluation:
Stereo photographs of the disc was assessed for
glaucomatous damage in the study subjects.20 The
photographs of the optic disc were mounted against an
illuminated background and assessed with Dodson’s viewer.
A diagnosis of primary open angle glaucoma (POAG) was
made if the following criteria were present:
- Vertical cup : disc ratio of 0.5 or more which corresponds to
the visual field defect
- Cup disc : asymmetry of 0.2 or more between the two eyes
- Thinning of the neuroretinal rim
- IOP of more than 21 mm Hg
Normal tension glaucoma was diagnosed when the above
criteria for POAG were present with a normal IOP ( 21 mm Hg
or less).
Primary angle closure glaucoma was diagnosed if narrow
or occludable angles were present on gonioscopy with visual
field defects and optic disc changes.
Ocular hypertension was defined as IOP > 21 mm Hg in
either eye on applanation tonometry without any visual field
or disc changes of glaucoma.
PHASE III OF CURES
Every sixth subject recruited in phase I was brought to the
Madras Diabetes Research Foundation. All these individuals
were subjected to the clinical, biochemical, special vascular
tests and detailed eye examination (Fig. 4).
Sub-studies in CURES:
Being a large population based study we are planning to
do several sub-studies in the CURES for answering various
questions related to diabetes and related disorders. The
recruitment procedure for these studies may vary.
Rural component:
The rural component of the CURES commenced in July
2003. Rural areas have been identified using the criteria that
they should be a minimum of 60 km away from Chennai.
Sampling techniques will be used to recruit study subjects
from these areas.
SUMMARY
CURES is one of the largest systematic population-based
studies on diabetes and the insulin resistance syndrome in
India. Together with the rural component we expect to have a
database of over 50,000 subjects representative of an urban
and rural area of Chennai. Once completed, this study is
expected to throw light on the prevalence and risk factors of
IRS in a native Indian population. Additional insights into
the effects of affluence on diabetes and associated metabolic
and cardiovascular disorders will also be obtained. Finally,
the study will provide data on the prevalence of retinopathy,
nephropathy and neuropathy in diabetic subjects.
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